Factors Affecting Immediate Anterior Implants Esthetics.

Factors Affecting Immediate Anterior Implants Esthetics . Clinical Retrospective Study

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07539168

Enrollment

500

Registered

2026-04-20

Start date

2026-06-01

Completion date

2026-09-01

Last updated

2026-04-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Immediate Implant Placement, Implant Survival Rate, Pink Esthetic Score

Keywords

Immediate implant, esthetics, anterior maxilla

Brief summary

This retrospective cohort study evaluates clinical, surgical, and prosthetic factors associated with early and mid-term outcomes of immediate implant placement in the anterior maxilla. The primary objective is to identify predictors of implant survival and complications (e.g., infection, soft-tissue dehiscence, esthetic failure) within 12 months following placement. Secondary objectives include assessment of peri-implant marginal bone loss, prosthetic complications, and esthetic outcomes (pink esthetic score).

Detailed description

Study design: Retrospective observational cohort study using existing patient records and radiographs from IDCE between September 2022 -March 2026. Data extraction will be performed blinded to outcome assessment. Participants: Subjects who received immediate implant placement in the anterior region (canine to canine) during the study period with at least 12 months follow-up. Expected sample size: approximately 500 patients/implants

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

21 Years to 55 Years

Healthy volunteers

Inclusion criteria

* flapless immediately placed implants in esthetic zone with 3 years follow up CBCT, * presence of immediate postoperative CBCT, * initial intact thick gingival biotype with at least 2 mm band of keratinized tissue * thin intact labial bone plate (\< 1mm) extending 7 mm apically assessed by CBCT with good apical bone * patients who had provided an informed consent.

Exclusion criteria

* patients with medical conditions that would compromise the surgical procedures, uncontrolled diabetes mellitus, taking IV bis-phosphonates for treatment of osteoporosis * patients with active infection related at the site of implant and patients with untreated active periodontal diseases.

Design outcomes

Primary

Measure	Time frame
Pink esthetic score	3 years

Contacts

CONTACTNourhan Gamal, MSc

Nourhannegamal259@gmail.com+201064249441

Outcome results